113 related articles for article (PubMed ID: 25500146)
1. Mortality within 30 days following systemic anti-cancer therapy, a review of all cases over a 4 year period in a tertiary cancer centre.
Khoja L; McGurk A; O'Hara C; Chow S; Hasan J
Eur J Cancer; 2015 Jan; 51(2):233-40. PubMed ID: 25500146
[TBL] [Abstract][Full Text] [Related]
2. Mortality within 30 days of receiving systemic anti-cancer therapy at a regional oncology unit: what have we learned?
Yoong J; Seah JA; Hamilton K; Teo LN; Chong G
Asia Pac J Clin Oncol; 2012 Dec; 8(4):325-9. PubMed ID: 22897423
[TBL] [Abstract][Full Text] [Related]
3. Thirty-day mortality after systemic anticancer treatment as a real-world, quality-of-care indicator: the Northland experience.
Ang E; Newton LV
Intern Med J; 2018 Apr; 48(4):403-408. PubMed ID: 28872748
[TBL] [Abstract][Full Text] [Related]
4. Mortality within 30 days of systemic anticancer therapy at a tertiary cancer centre: assessing the safety and quality of clinical care.
Wilson M; Mak W; Firth M; Deva S; Findlay M
N Z Med J; 2017 Aug; 130(1460):63-72. PubMed ID: 28796772
[TBL] [Abstract][Full Text] [Related]
5. The incidence and risk factors for short-term morbidity and mortality in pediatric deformity spinal surgery: an analysis of the NSQIP pediatric database.
Pugely AJ; Martin CT; Gao Y; Ilgenfritz R; Weinstein SL
Spine (Phila Pa 1976); 2014 Jul; 39(15):1225-34. PubMed ID: 24732856
[TBL] [Abstract][Full Text] [Related]
6. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with early mortality in non-small cell lung cancer patients following systemic anti-cancer therapy: A 10 year population-based study.
Gibson AJW; Li H; D'Silva A; Elegbede AA; Tudor RA; Otsuka S; Bebb DG; Cheung WY
Lung Cancer; 2019 Aug; 134():141-146. PubMed ID: 31319972
[TBL] [Abstract][Full Text] [Related]
8. Retrospective analysis of mortality within 30 days of systemic anticancer therapy and comparison with a previous audit at an Australian Regional Cancer Centre.
Zimbwa B; Gilbar PJ; Davis MR; Kondalsamy-Chennakesavan S
J Oncol Pharm Pract; 2022 Jul; 28(5):1077-1084. PubMed ID: 33990165
[TBL] [Abstract][Full Text] [Related]
9. Anticancer therapy at end-of-life: A retrospective cohort study.
Singh J; Stensvold A; Turzer M; Grov EK
Acta Oncol; 2024 May; 63():313-321. PubMed ID: 38716486
[TBL] [Abstract][Full Text] [Related]
10. Intensity of end-of-life health care and mortality after systemic anti-cancer treatment in patients with advanced lung cancer.
Oselin K; Pisarev H; Ilau K; Kiivet RA
BMC Cancer; 2021 Mar; 21(1):274. PubMed ID: 33722202
[TBL] [Abstract][Full Text] [Related]
11. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
[TBL] [Abstract][Full Text] [Related]
12. Cause of death in intensive care patients within 2 years of discharge from hospital.
Hicks PR; Mackle DM
Crit Care Resusc; 2010 Jun; 12(2):78-82. PubMed ID: 20513214
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and pattern of mortality in cancer patients at a tertiary care oncology center: report of 259 cases.
Prakash G; Bakhshi S; Raina V; Bhatnagar S; Sharma A; Kumar L; Shukla NK; Julka PK; Rath GK
Asian Pac J Cancer Prev; 2010; 11(6):1755-9. PubMed ID: 21338228
[TBL] [Abstract][Full Text] [Related]
14. Anticancer therapy within the last 30 days of life: results of an audit and re-audit cycle from an Australian regional cancer centre.
Nguyen M; Ng Ying Kin S; Shum E; Wann A; Tamjid B; Sahu A; Torres J
BMC Palliat Care; 2020 Jan; 19(1):14. PubMed ID: 31987038
[TBL] [Abstract][Full Text] [Related]
15. Radiation oncology quality: aggressiveness of cancer care near the end of life.
Toole M; Lutz S; Johnstone PA
J Am Coll Radiol; 2012 Mar; 9(3):199-202. PubMed ID: 22386167
[TBL] [Abstract][Full Text] [Related]
16. Survival benefit of transfer to tertiary trauma centers for major trauma patients initially presenting to nontertiary trauma centers.
Garwe T; Cowan LD; Neas B; Cathey T; Danford BC; Greenawalt P
Acad Emerg Med; 2010 Nov; 17(11):1223-32. PubMed ID: 21175521
[TBL] [Abstract][Full Text] [Related]
17. Morbidity, mortality, and quality-of-life outcomes of patients requiring >or=14 days of mechanical ventilation.
Combes A; Costa MA; Trouillet JL; Baudot J; Mokhtari M; Gibert C; Chastre J
Crit Care Med; 2003 May; 31(5):1373-81. PubMed ID: 12771605
[TBL] [Abstract][Full Text] [Related]
18. Hospital care for patients experiencing weekend vs weekday stroke: a comparison of quality and aggressiveness of care.
Kazley AS; Hillman DG; Johnston KC; Simpson KN
Arch Neurol; 2010 Jan; 67(1):39-44. PubMed ID: 20065127
[TBL] [Abstract][Full Text] [Related]
19. Experiences with Prescribing Large Quantities of Systemic Anticancer Therapy Near Death.
Baena-Cañada JM; Campini Bermejo A; Gámez Casado S; Rodríguez Pérez L; Quílez Cutillas A; Calvete Candenas J; Martínez Bautista MJ; Benítez Rodríguez E
J Palliat Med; 2019 Dec; 22(12):1515-1521. PubMed ID: 31184989
[No Abstract] [Full Text] [Related]
20. Systemic anti-cancer therapy patterns in advanced non-small cell lung cancer in Europe.
Hofmarcher T; Lindgren P; Wilking N
J Cancer Policy; 2022 Dec; 34():100362. PubMed ID: 36087918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
